Curare, a selective skeletal muscle relaxant, has been used clinically to reduce shivering and as an anesthetic auxiliary in abdominal surgery. It is also widely used in animal experiments to block neuromuscular junction activity. Eff ective doses of curare diminish muscle contraction without aff ecting brain function, but at higher doses it is known to be lethal. However, the exact dose of curare initiating muscle relaxation vs. lethal eff ect has not been fully characterized in mice. In this study we carefully examined the dose-response for achieving muscle inactivity over lethality in both male and female mice (C57BL6/J). The most striking fi nding of this study is that female mice were highly susceptible to curare; both the ED 50 and LD 50 were at least 3-fold lower than male littermates. This study shows that gender-specifi c diff erences can be an important factor when administering skeletal muscle relaxants, particularly curare or other analogous agents targeted to the neuromuscular junction.
INTRODUCTION
Curare has long been used by the Indians of South America as an arrow poison for hunting wild game (Bisset, 1992) . After it became known that curare aff ects voluntary muscles selectively without affecting the brain and heart it was widely used in modern medicine as an auxiliary in general anesthesia, frequently with cyclopropane (Anderson, 2010; Lee, 2003) . Curare has recently been used in humans to reduce shivering (Hovland et al., 2006) , and is also used in animal experimentation to block shivering (Hovland et al., 2006; Kashimura et al., 1992; Nonogaki et al., 1991) , to diagnose myasthenia gravis (a muscle disease) (Biesecker and Koffl er, 1988; Somnier and Trojaborg, 1993) and to manipulate neurosysnaptic transmission (Witoonpanich et al., 1989) etc. Curare acts as a neuromuscular blocking agent by binding to the acetylcholine receptor (AChR) at the neuromuscular junction and preventing nerve impulses from activating skeletal muscles (Bowman, 2006) . Although high doses of curare are lethal, low doses are well tolerated and the eff ect is completely reversible (Clement, 1978) . However, it is not known if curare has a gender-specific effect on physical activity and whole body metabolic rate. In this study we therefore examined the dose-dependent eff ects of curare on both male and female mice littermates by monitoring physical activity, core body temperature (Tc), whole animal oxygen consumption, circadian rhythm and feeding behavior.
METHODS
Experimental Animals: Age-matched (12-18 weeks old) male and female mice (C57BL/6J) littermates were housed at a temperature of 22±1 °C with a 12:12-h light: dark cycle and relative humidity about 50%. Diet (2014, Harlan Teklad) and water was provided ad libitum. The study protocol was Curare dose response: Tubocurarine hydrochloride (curare with better solubility profile) was purchased from SigmaAldrich, St. Louis, MO. Curare solution (0.9% NaCl solution) was administered intraperitonially in various quantities as reported in Table 1 . The mice were individually monitored for at least 30 minutes after treatment for drug eff ect. Dose and percentage of death were fi tted into a dose-response graph in GraphPad Prism 3.0 software to calculate the LD 50 (dose at which 50% of the mice died). From the dose-response curves an eff ective sub-lethal dose (ED i ), at which mice became immobile for few minutes, was determined for both male and female mice.
Monitoring of circadian rhythm and basal metabolic rate (BMR): To determine if administration of curare aff ects the metabolic rate in male and female mice diff erently, we measured oxygen consumption (VO 2 ), RER (respiratory exchange ratio) and physical activity (measured by infrared sensors installed around each housing cage). These experiments were performed at 25±1.0 °C using a Comprehensive Lab Animal Monitoring System (oxymax/CLAMS) equipped with a temperature-controlled environmental chamber from Columbus Instruments, Columbus, OH, USA. The mice were given ED i at 10AM following 18 hours acclimatization at 25±1.0 °C and metabolic measurements were recorded.
Core body Temperature measurement in mice exposed to cold: Core body temperature (Tc) was measured by thermal transponders (IPTT300, Bio Medic Data System, Seaford, DE). Mice were administered with ED i of curare and allowed to recover for 30 minutes and then challenged with 4 °C. Tc, oxygen consumption and physical activity were continuously monitored using oxymax/ CLAMS. Statistical analysis: Mortality data were analyzed using student't' test (nonparametric) using Graph pad Prism software and p < 0.05 was considered signifi cant.
RESULTS
We were interested in studying the role of muscle shivering over non-shivering thermogenic (NST) mechanisms contributing to heat production and Tc maintenance (Bal et al., 2012) . Therefore we chose to utilize curare, which has been shown to reduce shivering (Hovland et al., 2006; Kashimura et al., 1992) . We fi rst set out to optimize the dose that would minimize shivering by using diff erent doses of curare in both male and female mice. Interestingly, the LD 50 of curare for the female mice was very low (0.22 mg/kg) as compared to male mice (0.75 mg/kg) ( Figure 1A ). At doses below LD 50 , curare completely immobilizes the mice for ~10 minutes, after which mice can be used for experimental studies with maximal inhibition of shivering for the next ~5 hours. The ED 50 for achieving complete immobility was calculated to be 0.38 mg/kg for males, while that for the female mice was 0.01 mg/kg ( Figure 1A) . The diff erence in percentage mortality between male and female groups was found to be statistically signifi cant by applying a student't' test (p=0.003). The number of animals used in this study for each dose of curare and number of animals aff ected is presented in Table 1 . These data suggest that females are highly susceptible to curare and one-third dose for males is suffi cient to achieve complete immobility. Therefore, for all the remaining studies reported here, we chose 0.4 mg/kg for male and 0.1 mg/ kg for female mice as their respective eff ective dose to achieve immobility (ED i ). The immobility induced at these doses (0.4 mg/kg for male and 0.1 mg/kg for female mice) was completely reversible within ~10 minutes.
Administration of curare causes an immediate eff ect on physical activity and mice are immobilized for a short period. Therefore, we studied if curare has a long-lasting eff ect on metabolism (measured as whole body O 2 consumption) and physical activity on both male and female mice. O 2 consumption remained unchanged regardless of gender and dose administered (ED i ). Following curare (ED i ) administration, physical activity remained low for ~3 hours both in males ( Figure 2A ) and in females ( Figure 2B ). Other parameters, including Tc, respiratory exchange ratio (RER or respiratory quotient), energy expenditure measured at 25±1 °C did not show any signifi cant diff erence (Supplemental Figure) . At ED i , both male and female mice were able to tolerate the acute cold challenge of 4 °C (maintained Tc around 37.0 °C) and were able to upregulate their metabolism to meet the thermogenic demands during cold stress, which is refl ected in the increase in O 2 consumption ( Figure 2C and 2D) .
DISCUSSION
Curare has been used as a muscle relaxant in clinical surgery until recently, when safer alternatives became available. Many of these newer muscle relaxants have similar chemical structures/moieties and also have an analogous mode of action through AChR (Bowman, 2006) . Although widely used as a muscle relaxant in clinical surgery, gender-specifi c diff erences have not been reported previously. However, it was recently administered in a female patient to reduce shivering (Hovland et al., 2006) and one report suggested that female patients should receive a lower dose of curare (Bennett, 1968) , indicating that gender-specifi c diff erences may exist. This is the fi rst study to report that female mice are more sensitive to curare at a concentration three fold (LD 50 ) lower than males, but the exact mechanism is unclear. We used reproductively mature mice; the reproductive cycle of the female mice and their hormonal status were not considered. However, we expect that there is very little chance of overlap between the reproductive cycles of the 103 female mice used in the present study. Therefore, the role of reproductive hormones in the observed sensitivity of female mice to curare can be ruled out. This diff erence between males and females might be due to intrinsic gender-specifi c diff erences in recruitment and activation of neuromuscular junctions (Green et al., 1984; Simoneau et al., 1985) and/or gender-specifi c diff erences in ability of clearance of the drug from the body. Although the rate of metabolic clearance of curare in mice is not known, clearance for another plant-derived alkaloid, strychnine, has been reported to be slower in female mice, which may be the basis of higher sensitivity of female mice towards these alkaloids (Durkin, 2010) . Another interesting fi nding of this study is that the ED 50 and LD 50 for curare are close. Therefore, the curare dose for a given experiment should be chosen carefully to avoid lethality-induced diff erential results. Our study highlights the importance of a gender-specifi c diff erence in the curare doseresponse relationship. Therefore it calls for careful reevaluation of dose response in females before administering muscle relaxants including curare-like molecules.
